Concepedia

Michael P. Kane

MP

46

Publications

2K

Citations

23

H-Index

1981

Active since

Affiliations

Albany College of Pharmacy and Health Sciences(Current)

Rutgers Cancer Institute

Rutgers, The State University of New Jersey

Endocrine Society

Albany Medical Center Hospital

Michael P. Kane is an author at Albany College of Pharmacy and Health Sciences specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1981–2023

46

Publications

46

Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy

Hasan Rehman, Ann W. Silk, Michael P. Kane et al. · Journal for ImmunoTherapy of Cancer · 2016 · 359 citations · Full text

, , +16

Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer

Anshuman Panda, Janice M. Mehnert, Kim M. Hirshfield et al. · JNCI Journal of the National Cancer Institute · 2017 · 213 citations · Full text

Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer

Jenna H. Newman, Charles B. Chesson, Nora L. Herzog et al. · Proceedings of the National Academy of Sciences · 2019 · 185 citations · Full text

Safety and Efficacy of Exenatide in Combination with Insulin in Patients with Type 2 Diabetes Mellitus

Catherine A. Sheffield, Michael P. Kane, Robert Busch et al. · Endocrine Practice · 2008 · 81 citations

, , +6

Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Neutropenia during Phase I Development of Liposome-Entrapped Paclitaxel

Gerald J. Fetterly, Thaddeus H. Grasela, Jeffrey W. Sherman et al. · Clinical Cancer Research · 2008 · 70 citations · Full text

Rows per page

1–5 of 46